Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Chest
|
September 1, 1973
Alternation of the mitral opening click time in a patient with the Beall mitral valve prosthesis
A Benchimol, C L Harris, K B Desser
Journal of Immunological Methods
|
June 5, 1999
Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells
O B Spiller, C L Harris, B P Morgan
Biochemical Society Transactions
|
July 18, 2000
Therapeutic uses of recombinant complement receptors
B P Morgan, N K Rushmere, C L Harris
Biochemical Society Transactions
|
November 21, 2002
Tailoring anti-complement therapeutics
C L Harris, D A Fraser, B P Morgan
The Biochemical Journal
|
July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)
C L Harris, N K Rushmere, B P Morgan
Psychiatry
|
February 29, 2000
Posttraumatic obsessive-compulsive disorder: a three-factor model
W M Dinn, C L Harris, R C Raynard
Immunology
|
August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities
C L Harris, O B Spiller, B P Morgan
The Journal of Biological Chemistry
|
June 25, 1983
Cysteine starvation, isoleucyl-tRNAIle, and the regulation of the ilvGEDA operon of Escherichia coli
C L Harris, L Lui, S Sakallah, et al.
Cancer Research
|
December 1, 1975
RNA sulfurtransferase activity in rat liver and chemically induced hepatomas
C L Harris, F T Kerns, W St Clair
Brain and Cognition
|
August 31, 2001
Adult attention-deficit/hyperactivity disorder: neuropsychological correlates and clinical presentation
W M Dinn, N C Robbins, C L Harris
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Chest
|
September 1, 1973
Alternation of the mitral opening click time in a patient with the Beall mitral valve prosthesis
A Benchimol, C L Harris, K B Desser
Journal of Immunological Methods
|
June 5, 1999
Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells
O B Spiller, C L Harris, B P Morgan
Biochemical Society Transactions
|
July 18, 2000
Therapeutic uses of recombinant complement receptors
B P Morgan, N K Rushmere, C L Harris
Biochemical Society Transactions
|
November 21, 2002
Tailoring anti-complement therapeutics
C L Harris, D A Fraser, B P Morgan
The Biochemical Journal
|
July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)
C L Harris, N K Rushmere, B P Morgan
Psychiatry
|
February 29, 2000
Posttraumatic obsessive-compulsive disorder: a three-factor model
W M Dinn, C L Harris, R C Raynard
Immunology
|
August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities
C L Harris, O B Spiller, B P Morgan
The Journal of Biological Chemistry
|
June 25, 1983
Cysteine starvation, isoleucyl-tRNAIle, and the regulation of the ilvGEDA operon of Escherichia coli
C L Harris, L Lui, S Sakallah, et al.
Cancer Research
|
December 1, 1975
RNA sulfurtransferase activity in rat liver and chemically induced hepatomas
C L Harris, F T Kerns, W St Clair
Brain and Cognition
|
August 31, 2001
Adult attention-deficit/hyperactivity disorder: neuropsychological correlates and clinical presentation
W M Dinn, N C Robbins, C L Harris
Page
of 10